Professor Gerald Holtmann
Professor

Gerald Holtmann

Email: 
Phone: 
+61 7 3176 7792

Background

Prof Holtmann is a Clinical Academic in the field of Gastroenterology & Hepatology and Director of Clinical Innovation. He is also Director of the Department of Gastroenterology & Hepatology at the Princess Alexandra Hospital in Queensland and serves on the Board of Directors of the West Moreton Hospital and Health Service and UQ Healthcare. He is a Fellow of Royal Australian Collge of Physicians (RACP, Sydney), the Royal College of Physicians (RCP, London) and Fellow of the Australian Academy of Health and Medical Sciences (AAHMS, Canberra). Besides his Medical Qualifications he also obtained a Master of Business Administration. After completing the clinical training in Medicine and Gastroenterology at the University of Essen in Germany and the Mayo Clinic in Rochester, Minnesota in the United States, he has gained substantial leadership and managerial experience within the health care setting as Director of large Gastroenterology Departments, CEO and General Manager of a University Hospital and Health Care Facilities and has served on the Board of the University Hospital Essen in Germany. His research is in the field of Neurogastroenterology has resulted in peer reviewed publications in key journal including the NEJM, Lancet, Gastroenterology and Gut. More recently his rersearch focus is on the role of the gut microbiome, mucosal and systemic inflammation and brain-gut interactions.

Availability

Professor Gerald Holtmann is:
Available for supervision
Media expert

Search Professor Gerald Holtmann’s works on UQ eSpace

546 works between 1986 and 2025
All (546) Journal Article (405) Conference Publication (137) Book Chapter (4)

401 - 420 of 546 works

2005

Journal Article

Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia

Adam, B., Liebregts, T., Saadat-Gilani, K., Vinson, B. and Holtmann, G. (2005). Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia. Alimentary Pharmacology and Therapeutics, 22 (4), 357-363. doi: 10.1111/j.1365-2036.2005.02572.x

Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia

2005

Journal Article

Understanding GERD symptoms in the clinical setting

Holtmann, Gerald (2005). Understanding GERD symptoms in the clinical setting. Drugs of today (Barcelona, Spain : 1998), 41 Suppl B (SUPPL. B), 13-7. doi: 10.1358/dot.2005.41.1.875775

Understanding GERD symptoms in the clinical setting

2005

Journal Article

Effect of E. coli Nissle 1917 on post-inflammatory visceral sensory function in a rat model

Liebregts, T., Adam, B., Bertel, A., Jones, S., Schulze, J., Enders, C., Sonnenborn, U., Lackner, K. and Holtmann, Gerald (2005). Effect of E. coli Nissle 1917 on post-inflammatory visceral sensory function in a rat model. Neurogastroenterology and Motility, 17 (3), 410-414. doi: 10.1111/j.1365-2982.2005.00638.x

Effect of E. coli Nissle 1917 on post-inflammatory visceral sensory function in a rat model

2005

Journal Article

Irritable bowel syndrome Das reizdarmsyndrom

Adam, B., Liebregts, T. and Holtmann, G. (2005). Irritable bowel syndrome Das reizdarmsyndrom. Deutsche Medizinische Wochenschrift, 130 (8), 399-401. doi: 10.1055/s-2005-863064

Irritable bowel syndrome Das reizdarmsyndrom

2005

Journal Article

MR colonography in patients with incomplete conventional colonoscopy

Ajaj, Waleed, Lauenstein, Thomas C., Pelster, Gregor, Holtmann, Gerald, Ruehm, Stefan G., Debatin, Joerg F. and Goehde, Susanne C. (2005). MR colonography in patients with incomplete conventional colonoscopy. Radiology, 234 (2), 452-459. doi: 10.1148/radiol.2342032001

MR colonography in patients with incomplete conventional colonoscopy

2005

Journal Article

Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation

Müller-Lissner, S., Holtmann, G., Rueegg, P., Weidinger, G. and Löffler, H. (2005). Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation. Alimentary Pharmacology and Therapeutics, 21 (1), 11-20. doi: 10.1111/j.1365-2036.2004.02294.x

Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation

2005

Journal Article

Global endpoints in functional gastrointestinal disease [2] (multiple letters)

Mangel, A. W., Fehnel, S. E., Adam, B., Liebregts, T. and Holtmann, G. (2005). Global endpoints in functional gastrointestinal disease [2] (multiple letters). Alimentary Pharmacology and Therapeutics, 22 (11-12), 1162-1163. doi: 10.1111/j.1365-2036.2005.02708.x

Global endpoints in functional gastrointestinal disease [2] (multiple letters)

2005

Journal Article

Susceptibility genes and functional gastrointestinal disorders

Liebregts, T., Adam, B. and Holtmann, G. (2005). Susceptibility genes and functional gastrointestinal disorders. Journal of Gastroenterology and Hepatology (Australia), 20 (11), 1792-1793. doi: 10.1111/j.1440-1746.2005.04163.x

Susceptibility genes and functional gastrointestinal disorders

2004

Journal Article

IBS: A syndrome or many diseases?

Holtmann, Gerald (2004). IBS: A syndrome or many diseases?. Best Practice and Research: Clinical Gastroenterology, 18 (SUPPL.), 91-97. doi: 10.1016/j.bpg.2004.06.017

IBS: A syndrome or many diseases?

2004

Journal Article

Review article: oesophageal complications and consequences of persistent gastro-oesophageal reflux disease

Pisegna, J, Holtmann, G, Howden, C W, Katelaris, P H, Sharma, P, Spechler, S, Triadafilopoulos, G and Tytgat, G (2004). Review article: oesophageal complications and consequences of persistent gastro-oesophageal reflux disease. Alimentary pharmacology & therapeutics, 20 Suppl 9 (9), 47-56. doi: 10.1111/j.1365-2036.2004.02240.x

Review article: oesophageal complications and consequences of persistent gastro-oesophageal reflux disease

2004

Journal Article

Visceral hyperalgesia and intestinal dysmotility following infection Viszerale hyperalgesie und gestörte darmmotilität als infektionsfolge

Adam, B., Bechmann, L. P. and Holtmann, Gerald (2004). Visceral hyperalgesia and intestinal dysmotility following infection Viszerale hyperalgesie und gestörte darmmotilität als infektionsfolge. Zeitschrift fur Gastroenterologie, 42 (11), 1331-1332. doi: 10.1055/s-2004-813701

Visceral hyperalgesia and intestinal dysmotility following infection Viszerale hyperalgesie und gestörte darmmotilität als infektionsfolge

2004

Journal Article

Heartburn in primary care: Problems below the surface

Holtmann, Gerald, Maldonado-Lopez, Evelyn and Haag, Sebastian (2004). Heartburn in primary care: Problems below the surface. Journal of Gastroenterology, 39 (11), 1027-1034. doi: 10.1007/s00535-004-1440-8

Heartburn in primary care: Problems below the surface

2004

Journal Article

A comparison of symptom intensity in patients with irritable bowel syndrome in primary and secondary care Ein vergleich der symptomintensität bei patienten mit reizdarmsyndrom in der primär- und sekundärversorgung

Liebregts, T., Best, J. and Holtmann, G. (2004). A comparison of symptom intensity in patients with irritable bowel syndrome in primary and secondary care Ein vergleich der symptomintensität bei patienten mit reizdarmsyndrom in der primär- und sekundärversorgung. Zeitschrift fur Gastroenterologie, 42 (11), 1329-1330. doi: 10.1055/s-2004-813614

A comparison of symptom intensity in patients with irritable bowel syndrome in primary and secondary care Ein vergleich der symptomintensität bei patienten mit reizdarmsyndrom in der primär- und sekundärversorgung

2004

Journal Article

Evidence-based medicine and phytotherapy for functional dyspepsia and irritable bowel syndrome: A systematic analysis of evidence for the herbal preparation Iberogast® Evidenz-basierte medizin und phytotherapie bei funktioneller dyspepsie und reizdarmsyndrom: Eine systematische analyse der verfügbaren evidenz zum präparat iberogast®

Holtmann, Gerald, Adam, Birgit and Vinson, Bettina (2004). Evidence-based medicine and phytotherapy for functional dyspepsia and irritable bowel syndrome: A systematic analysis of evidence for the herbal preparation Iberogast® Evidenz-basierte medizin und phytotherapie bei funktioneller dyspepsie und reizdarmsyndrom: Eine systematische analyse der verfügbaren evidenz zum präparat iberogast®. Wiener Medizinische Wochenschrift, 154 (21-22), 528-534. doi: 10.1007/s10354-004-0119-3

Evidence-based medicine and phytotherapy for functional dyspepsia and irritable bowel syndrome: A systematic analysis of evidence for the herbal preparation Iberogast® Evidenz-basierte medizin und phytotherapie bei funktioneller dyspepsie und reizdarmsyndrom: Eine systematische analyse der verfügbaren evidenz zum präparat iberogast®

2004

Journal Article

Symptom patterns in functional dyspepsia and irritable bowel syndrome: Relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters

Haag, S., Talley, N. J. and Holtmann, G. (2004). Symptom patterns in functional dyspepsia and irritable bowel syndrome: Relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters. Gut, 53 (10), 1445-1451. doi: 10.1136/gut.2003.030049

Symptom patterns in functional dyspepsia and irritable bowel syndrome: Relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters

2004

Journal Article

Real time high resolution magnetic resonance imaging for the assessment of gastric motility disorders

Ajaj, W., Goehde, S. C., Papanikolaou, N., Holtmann, G., Ruehm, S. G., Debatin, J. F. and Lauenstein, T. C. (2004). Real time high resolution magnetic resonance imaging for the assessment of gastric motility disorders. Gut, 53 (9), 1256-1261. doi: 10.1136/gut.2003.038588

Real time high resolution magnetic resonance imaging for the assessment of gastric motility disorders

2004

Journal Article

Molecular basis of functional gastrointestinal disorders

Holtmann, Gerald, Liebregts, Tobias and Siffert, Winfried (2004). Molecular basis of functional gastrointestinal disorders. Best Practice and Research: Clinical Gastroenterology, 18 (4), 633-640. doi: 10.1016/j.bpg.2004.04.006

Molecular basis of functional gastrointestinal disorders

2004

Journal Article

Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia: A randomized, double-blind placebo-controlled crossover study

Holtmann, Gerald, Kutscher, Sven-Uwe, Haag, Sebastian, Langkafel, Mathias, Heuft, Gereon, Neufang-Hueber, Jutta, Goebell, Harald, Senf, Wolfgang and Talley, Nicholas J. (2004). Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia: A randomized, double-blind placebo-controlled crossover study. Digestive Diseases and Sciences, 49 (4), 672-679. doi: 10.1023/B:DDAS.0000026317.00071.75

Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia: A randomized, double-blind placebo-controlled crossover study

2004

Journal Article

Are There Alterations of Neuroendocrine and Cellular Immune Responses to Nutrients in Women with Irritable Bowel Syndrome?

Elsenbruch, Sigrid, Holtmann, Gerald, Oezcan, Deniz, Lysson, Andreas, Janssen, Onno, Goebel, Marion U. and Schedlowski, Manfred (2004). Are There Alterations of Neuroendocrine and Cellular Immune Responses to Nutrients in Women with Irritable Bowel Syndrome?. American Journal of Gastroenterology, 99 (4), 703-710. doi: 10.1111/j.1572-0241.2004.04138.x

Are There Alterations of Neuroendocrine and Cellular Immune Responses to Nutrients in Women with Irritable Bowel Syndrome?

2004

Journal Article

[Functional dyspepsia]

Haag, S and Holtmann, G (2004). [Functional dyspepsia]. MMW Fortschritte der Medizin, 146 (14), 51-2.

[Functional dyspepsia]

Current funding

  • 2022 - 2026
    ARC Training Centre for Behavioural Insights for Technology Adoption (BITA) (ARC Industrial Transformation Training Centre Administered by QUT)
    Queensland University of Technology
    Open grant
  • 2021 - 2025
    A practice change for patients with severe chronic, clinically unexplained gastrointestinal symptoms: A randomised, controlled intervention to assess efficacy and cost-effectiveness
    NHMRC IDEAS Grants
    Open grant

Past funding

  • 2020 - 2024
    Modulation of the Gastrointestinal Microbiome with probiotics and subsequent Methane production as a novel approach to treat constipation: A Proof of Principle Study (TRI Sport Grant led by PAH)
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2025
    Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network Study
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2019 - 2024
    Centre for Research Excellence in Digestive Health (NHMRC CRE administered by University of Newcastle)
    University of Newcastle
    Open grant
  • 2016
    Establishing a gnotobiotic germ-free mouse facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    The Australian human microbiota project-microbe isolation facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2018
    Pathophysiology of functional dyspepsia: Integration of upper gut function, inflammation and a systems biology approach.
    NHMRC Project Grant
    Open grant
  • 2014 - 2017
    Functional dyspepsia: Characterisation of the immunopathology and testing a novel therapeutic strategy (NHMRC Project Grant administered by the University of Newcastle)
    University of Newcastle
    Open grant

Availability

Professor Gerald Holtmann is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Effects the COVID-19 pandemic on the outcome and management of highly prevalent gastrointestinal conditions

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Reimagining Health Equity and Access in Colorectal Cancer Screening. A population perspective.

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    IBD and mental health tools: a holistic approach to discovery and appropriate tool.

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Study of TOfacitinib for the treatment of chronic Pouchitis

    Associate Advisor

    Other advisors: Associate Professor Jakob Begun

  • Doctor Philosophy

    Exercise training on people with severe chronic, clinically unexplained gastrointestinal symptoms: A randomised, controlled trial.

    Associate Advisor

    Other advisors: Professor Jeff Coombes

  • Doctor Philosophy

    The role of the gut microbiome in alcohol related liver disease

    Associate Advisor

    Other advisors: Professor Jason Connor, Dr Paul Clark

Completed supervision

Enquiries

Contact Professor Gerald Holtmann directly for media enquiries about:

  • colon cancer screening
  • Gastroenterology
  • Gut Health
  • Microbiome
  • Neurogastroenterology

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au